CiteFacts · FDA Drug Shortages · FDA source
Azacitidine Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Accord Healthcare Inc. | Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Available | 08/17/2026 |
| Armas Pharmaceuticals Inc | Azacitidine, Injection, 100 mg (NDC 72485-201-01) | Limited Availability | 06/08/2026 |
| Bristol Myers Squibb Co. | Vidaza, Injection, 100 mg (NDC 59572-102-01) | Available | 08/16/2026 |
| Dr. Reddy's Laboratories, Inc. | Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Available | 08/05/2026 |
| Eugia US LLC | Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Unavailable | 08/06/2026 |
| Fresenius Kabi USA, LLC | Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Unavailable | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Available | 08/13/2026 |
| Meitheal Pharmaceuticals, Inc. | Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Available | 06/01/2026 |
| Teva Pharmaceuticals USA, Inc. | Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Unavailable | 08/17/2026 |
Source facts
Grouped generic ingredient: Azacitidine Injection · 9 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Oncology
Dosage forms: Injection
Routes: INTRAVENOUS, SUBCUTANEOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.